<--- Back to Details
First PageDocument Content
Leukotriene antagonists / Cyclopropanes / Clinical research / Alkenes / Merck / Montelukast / Food and Drug Administration / Pharmacometrics / Pharmacology / Chemistry / Pharmaceutical sciences
Leukotriene antagonists
Cyclopropanes
Clinical research
Alkenes
Merck
Montelukast
Food and Drug Administration
Pharmacometrics
Pharmacology
Chemistry
Pharmaceutical sciences

20829 Montelukast Clinpharm PREA

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 73,62 KB

Share Document on Facebook

Similar Documents

Certara Strategic Consulting: Drug Development and Pharmacometrics Leadership Certara Strategic Consulting, the largest and most comprehensive model-informed drug development and strategic pharmacometrics organization, b

Certara Strategic Consulting: Drug Development and Pharmacometrics Leadership Certara Strategic Consulting, the largest and most comprehensive model-informed drug development and strategic pharmacometrics organization, b

DocID: 1tQbt - View Document

GUIDE TO AUTHORS ABOUT THE JOURNAL SCOPE CPT: Pharmacometrics & Systems Pharmacology is a cross-disciplinary journal devoted to publishing

GUIDE TO AUTHORS ABOUT THE JOURNAL SCOPE CPT: Pharmacometrics & Systems Pharmacology is a cross-disciplinary journal devoted to publishing

DocID: 1lAcz - View Document

J Pharmacokinet Pharmacodyn:3 DOIs10928x COMMENTARY  Affiliation between the American Society of Pharmacometrics

J Pharmacokinet Pharmacodyn:3 DOIs10928x COMMENTARY Affiliation between the American Society of Pharmacometrics

DocID: 1kzIM - View Document

Application of Shiny in Pharmacometrics, October 23rd, 2013 Brian Corrigan, PHD Clinical Pharmacology Pfizer, Groton, CT

Application of Shiny in Pharmacometrics, October 23rd, 2013 Brian Corrigan, PHD Clinical Pharmacology Pfizer, Groton, CT

DocID: 1kx7a - View Document

JCPJCP CE Activities Log onto https://accp1.inreachce.com/ to access these activities. Clinical Response JCP - August, 2014: Positive Clinical Response to Clopidogrel is Independent of Paraoxonase I Q192R and CYP2C19 Gen

JCPJCP CE Activities Log onto https://accp1.inreachce.com/ to access these activities. Clinical Response JCP - August, 2014: Positive Clinical Response to Clopidogrel is Independent of Paraoxonase I Q192R and CYP2C19 Gen

DocID: 1ftMp - View Document